Signs Your Hospital Infection Was Caused by an Olympus Scope — Not Just Bad Luck

Hospital-acquired infections happen for many reasons. Most are unrelated to the scope itself. But a specific subset of post-procedure infections has clinical signatures that strongly suggest a contaminated endoscope was the source. If your timeline matches several of the markers below, the case is worth a closer look.

Signal #1: The Infection Started Within Days or Weeks of a Scope Procedure

Scope-related infections typically show symptoms within 7 to 30 days after the procedure. Most surface within the first two weeks. The most common procedures are colonoscopy, ERCP (endoscopic retrograde cholangiopancreatography), upper endoscopy (EGD), and bronchoscopy.

If you went into the hospital or outpatient endoscopy suite feeling fine, had a scope procedure, and were back in the ER within two weeks with fever, chills, abdominal pain, or sepsis — that timeline is the first signal. It rules out community-acquired infections that take longer to develop and points to something introduced during the procedure itself.

Signal #2: The Organism Is a Multi-Drug-Resistant "Superbug"

Contaminated endoscopes have been linked specifically to multi-drug-resistant organisms (MDROs) that are difficult to acquire any other way. The names that appear over and over in scope outbreaks include:

• Carbapenem-Resistant Enterobacteriaceae (CRE) — including CRKP (Klebsiella pneumoniae) and CR E. coli.
• Pseudomonas aeruginosa, especially multi-drug-resistant strains.
• MRSA (methicillin-resistant Staph aureus) in certain bronchoscope-related outbreaks.
• VRE (vancomycin-resistant Enterococcus) in some duodenoscope clusters.
• Mycobacterium chimaera and other atypical mycobacteria in select scope incidents.

These organisms live in biofilms inside scope working channels and elevator mechanisms that survive standard reprocessing. If the discharge papers or culture report from your hospitalization name one of these pathogens, the link is much stronger than for ordinary infections.

Signal #3: Other Patients at the Same Facility Got Sick Too

Endoscope outbreaks tend to cluster. When a scope is contaminated, it does not infect one patient — it infects a sequence of patients over days or weeks until the device is identified and pulled. If you can find evidence that other patients at the same facility, in the same general time frame, came down with similar infections, that is the strongest single signal in any of these cases.

Sources for that information include local newspaper coverage, hospital infection-control notifications, state public health reports, CDC's NHSN database (in aggregate form), and FDA's MAUDE adverse event database. Our investigators check all of these when we evaluate a case.

Signal #4: An Olympus Scope Was Used — Especially a TJF, CF, GIF, or BF Model

The FDA's June 2025 import alert specifically named 58 Olympus device models manufactured at the company's Aizu, Japan facility. The model families most commonly implicated in U.S. scope outbreaks include:

• TJF-Q180V and TJF-160F — duodenoscopes used in ERCP. The closed-channel elevator mechanism is the design defect at the heart of the litigation.
• CF series — colonoscopes.
• GIF series — gastroscopes used in upper endoscopy.
• BF series — bronchoscopes used in pulmonary procedures.

Identifying which specific scope was used in your procedure requires the operative report or the device tracking log from the endoscopy suite. Our guide on how to find out which scope was used walks through exactly how to request that information.

Signal #5: The Hospital Has Not Been Forthcoming

Patients in scope-outbreak cases often report a familiar pattern: when they ask which scope was used, the hospital is vague. When they ask whether other patients have been affected, the answer is "we can't discuss other patients." When they ask whether the scope was tested after their procedure, no one knows. When they ask for the device tracking number, the records department needs to "get back to them."

Lack of transparency is not proof of anything by itself. But combined with the other signals on this list, it is part of the picture. Once a lawsuit is filed, we have legal mechanisms to compel the disclosure of the device serial number, reprocessing logs, and infection-control records the hospital has not voluntarily produced.

What These Signals Are Not

None of the five signals above proves causation by itself. Every infection case requires a careful workup that ties the specific patient, the specific procedure, the specific device, and the specific organism into a chain a jury can follow. Some infections that look like scope outbreaks turn out to be something else. Some that look like ordinary post-op complications turn out, on close review, to be the tip of an unreported outbreak.

The point of the five signals is to give patients and families a framework for asking the right questions. If three or more match your situation, the case is worth a free evaluation.

What to Do Next

• Request your full medical records from the facility that performed the scope and from any hospital that treated the infection.
• Request the operative report and device tracking log specifically. These are not always included in a standard records request and may need to be asked for by name.
• Save culture and lab reports that identify the organism. These are the most important single documents in any scope case.
• Do not delay because of the statute of limitations. Each state has its own filing deadline. Read our companion piece on how long you have to file.

A free case review takes about 15 minutes by phone. We represent patients nationwide, regardless of where the procedure happened. There is no fee unless we recover money for you.

Sources

• U.S. Food & Drug Administration — "Import Alerts for Certain Olympus Medical Devices Manufactured in Japan: Letter to Health Care Providers." fda.gov
• Centers for Disease Control and Prevention — "Antibiotic Resistance Threats in the United States." cdc.gov
• U.S. FDA MAUDE Adverse Event Database. accessdata.fda.gov